AGN-207281 ophthalmic solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGN-207281 ophthalmic solution, covering 2012-01-16 to 2012-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1]